Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Interim phase II data disclosed on nimotuzumab plus irinotecan in gastric cancer

Jan. 25, 2011

CHMP recommends approval of Jevtana combination regimen for prostate cancer

Jan. 24, 2011

Vidaza approved in Japan for myelodysplastic syndromes

Jan. 24, 2011

New inhibitors of hepatocyte growth factor receptor claimed

Jan. 24, 2011

New inhibitors of heat shock protein HSP 90 presented

Jan. 24, 2011

Parthenolide sensitizes osteosarcoma cells to radiation

Jan. 24, 2011

Combination therapies including cediranib well tolerated in patients with gastric cancer

Jan. 24, 2011

Crizotinib suppresses osteosarcoma and associated osteolytic/osteoblastic changes in vivo

Jan. 24, 2011

CHMP issues positive opinion on European orphan drug status for darinaparsin in PTCL

Jan. 21, 2011

FDA sets PDUFA date for Adventrx's Exelbine NDA

Jan. 21, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...